Benelux Venture 50 - Winners 2009
Out of the Benelux Venture 50 companies selected to present at the Benelux Venture Forum 2009, the international experts reviewing presentations at the event, chose the 9 most promising candidates as published here below:
Cleantech Session I: Epuramat
"We are very proud being selected among the Top presenting companies. The Investor feedback encouraged us being on the right track with our “ExSep”-technology for a highly efficient wastewater treatment and the business model we follow within that fierce competing market."
Dr. David Din (coCEO) Epuramat
Cleantech Session II: FeyeCon
"FeyeCon is thrilled to have been given the opportunity to take part in the Benelux Venture Forum. I found the forum to be informative, inspirational and of course a fantastic opportunity to network. Your event captured the entrepreneurial spirit, which was so passionately displayed by our fellow participants. We are honored to have been selected as one of the winners and very much look forward to participating in the next steps leading up to the European Venture Summit."
Dr. Maaike van Roosmalen (Managing Director) FeyeCon
Life Sciences Session I: Cardio3BioSciences
Cardio3 BioSciences is a leading Belgian biotechnology company specialising in cell-based therapies for the treatment of cardiovascular diseases.
“I would like to thank the Benelux Venture Forum for selecting us between the 50 most promising Benelux companies presenting at the Forum. It was a great opportunity for Cardio3 BioSciences, a young belgian biotechnical company, to present our corporate overview, and to share our scientific program and innovative technology, in such a difficult global environment”.
Christian Homsy (CEO) Cardio3 BioSciences
Life Sciences Session II: arGEN-X
"The arGEN-X team is honored to be amongst the winners of this prestigious competition. It is a recognition of our innovation achievements and testimony to the tremendous value creation potential of the Company’s SIMPLE Antibody™ technology."
Tim van Hauwermeiren (CEO) arGEN-X
Life Sciences Session III: ActoGenix
"During recent years the Benelux region has emerged as one with rapidly expanding biotech industry. For me as biotech entrepreneur, the Benelux Venture Forum has provided an excellent opportunity to meet with key players in this industry, both from the financing as well as the corporate side."
Dr. Mark Vaeck (CEO) ActoGeniX NV
ICT Session I: Liquavista
"We are very pleased to have been elected one of the top ventures in the Benelux area. This is a major recognition of the huge potential of Liquavista’s technology to have a profound impact on today’s display industry.”
Johan Feenstra (CTO and Founder) Liquavista
ICT Session II: IASO Backup
"I have enjoyed the refreshingly positive spirit of entrepreneurship at the Benelux Venture Forum and am delighted that IASO has been selected a winner. I am convinced that even in challenging times the combination of smart money and good business can create great value."
Rob Verbeek (CEO) IASO Backup
ICT Session III: Softkinetic
"It is the second time that Softkinetic participates to the Benelux Venture Forum. Like in 2008, this event has allowed us to expose our project to a panel of professional investors and advisors, in an efficient, direct and focused manner. We have already secured three follow-up meetings with interested investors as a result of our presentation. We look forward to continue partnering with Europe Unlimited to build up our network."
Michel Tombroff (CEO) Softkinetic
ICT Session IV: Bliin
"Thank you BVF for a great networking event & presentation opportunity. We believe it may prove to be instrumental for the immediate growth of our venture."
Kolman Stef (Founder & VP Technology) Bliin
ICT Session IV: IRL Connect
"IRL Connect is thrilled to be one of the winners from the Benelux Venture 50 and move onto the semifinals this fall. E-Unlimited events are an excellent opportunity for us to talk one on one with the venture community&
